Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

NCT02974686 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped low recruitment

Conditions

Kidney Transplant Rejection
Gastrointestinal Disorder, Functional

Interventions

DRUG: Everolimus
DRUG: Mycophenolic Acid

Sponsor

Washington University School of Medicine

Collaborators

[object Object]